Lactic acidosis previously has been reported during treatment of asthm
a with beta-2 agonists, However, this metabolic disturbance never had
am clinical consequence, We report a case of a patient with asthma in
whom beta-2 agonist administration increased dyspnea by metabolic acid
osis due to a sharp increase in lactate levels (hyperlactatemia) and l
ed to inappropriate intensification of bronchodilator therapy.